Skip to main content
Top
Published in: European Journal of Epidemiology 8/2020

01-08-2020 | COVID-19 Vaccination | VACCINE HESITANCY

Vaccine hesitancy: the next challenge in the fight against COVID-19

Authors: Amiel A. Dror, Netanel Eisenbach, Shahar Taiber, Nicole G. Morozov, Matti Mizrachi, Asaf Zigron, Samer Srouji, Eyal Sela

Published in: European Journal of Epidemiology | Issue 8/2020

Login to get access

Abstract

Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates.
Literature
1.
go back to reference Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576–7.CrossRef Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576–7.CrossRef
2.
go back to reference Omer SB, Salmon DA, Orenstein WA, DeHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. NEJM. 2009;360:1981–8.CrossRef Omer SB, Salmon DA, Orenstein WA, DeHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. NEJM. 2009;360:1981–8.CrossRef
4.
go back to reference Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.CrossRef Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.CrossRef
5.
go back to reference Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis. 2012;25:243–9.CrossRef Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis. 2012;25:243–9.CrossRef
6.
go back to reference Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Heal. 2020;4:421.CrossRef Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Heal. 2020;4:421.CrossRef
7.
go back to reference Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–60.CrossRef Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–60.CrossRef
8.
go back to reference Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35:325–30.CrossRef Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35:325–30.CrossRef
9.
go back to reference Corey BL, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948–50.CrossRef Corey BL, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948–50.CrossRef
10.
go back to reference Dean NE, Gsell P-S, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, et al. Design of vaccine efficacy trials during public health emergencies. Sci Transl Med. 2019;11:eaat0360.CrossRef Dean NE, Gsell P-S, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, et al. Design of vaccine efficacy trials during public health emergencies. Sci Transl Med. 2019;11:eaat0360.CrossRef
Metadata
Title
Vaccine hesitancy: the next challenge in the fight against COVID-19
Authors
Amiel A. Dror
Netanel Eisenbach
Shahar Taiber
Nicole G. Morozov
Matti Mizrachi
Asaf Zigron
Samer Srouji
Eyal Sela
Publication date
01-08-2020
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 8/2020
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-020-00671-y

Other articles of this Issue 8/2020

European Journal of Epidemiology 8/2020 Go to the issue